Advertisement
Journal Home
Search for

Volume 81, Issue 1, Pages 1-7 (January 2010)


View previous. 3 of 19 View next.

Mifepristone: ten years later

Eric A. SchaffCorresponding Author Information1email address

Received 17 May 2009; received in revised form 19 July 2009; accepted 11 August 2009. published online 05 October 2009.

Abstract 

While pregnant women have sought abortifacients for thousands of years, they had no success at finding one that both worked and did not jeopardize their lives in the process. The discovery of mifepristone, with both anti-glucocorticoid and anti-progesterone properties, has had a profound effect on women's lives while weaving the abortion-related political hazards. Despite the controversies, millions of women around the world have used mifepristone for medical abortion. This review describes how researchers addressed the numerous barriers of a mifepristone abortion (i.e., gestational age limitation, lengthy process, high costs, complex regimen, failures, side effects and complications) and continue to improve upon the limited numbers and types of clinicians offering mifepristone.

Director of Adolescent Medicine, Department of Pediatrics, Temple University School of Medicine, Philadelphia, PA 19140, USA

Corresponding Author InformationTel.: +1 585 233 2124; fax: +1 866 585 0371.

1 Formerly affiliated with Department of Family Medicine, University at Buffalo, Buffalo, NY, USA.

PII: S0010-7824(09)00382-5

doi:10.1016/j.contraception.2009.08.004


View previous. 3 of 19 View next.

Advertisement